Programs and Studies

ACTC

The goal of the Alzheimer’s Clinical Trials Consortium (ACTC) is to provide an optimal infrastructure, utilizing centralized resources and shared expertise, to accelerate the development of effective interventions for Alzheimer’s disease and related disorders. Biostatistics faculty and staff direct and staff the ACTC Biostatistics Unit. The Biostatistics team works on the following studies: AHEAD, A4, LiBBY, START.